Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
Authors
Keywords
Cytotoxic T lymphocyte, Immune response, Immunotherapy, Oesophageal adenocarcinoma, Regulatory T cells, Tumour regression
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 6, Pages 651-662
Publisher
Springer Nature
Online
2016-03-28
DOI
10.1007/s00262-016-1826-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
- (2014) Ezzeldin M. Ibrahim et al. BREAST CANCER RESEARCH AND TREATMENT
- Strategies to improve outcomes in esophageal adenocarcinoma
- (2014) Andrew Cowie et al. Expert Review of Anticancer Therapy
- Critical role of spatial interaction between CD8+ and Foxp3+ cells in human gastric cancer: the distance matters
- (2013) Anita Feichtenbeiner et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers
- (2013) Kyung-Ju Kim et al. HUMAN PATHOLOGY
- Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients – an immunohistochemical study of cd8+ and foxp3+ using double immunostaining with correlation to the pathobiological response of the patients
- (2013) Monica SM Chan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer
- (2013) Fergus Noble et al. MEDICAL ONCOLOGY
- Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus
- (2013) Fergus Noble WORLD JOURNAL OF GASTROENTEROLOGY
- The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma
- (2012) Nigel B. Jamieson et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
- (2012) Hui Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
- (2012) Foluso O. Ademuyiwa et al. PLoS One
- Interrelationships between Tumor Proliferative Activity, Leucocyte and Macrophage Infiltration, Systemic Inflammatory Response, and Survival in Patients Selected for Potentially Curative Resection for Gastroesophageal Cancer
- (2011) Andrew B. C. Crumley et al. ANNALS OF SURGICAL ONCOLOGY
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
- (2011) Michael J. Proctor et al. EUROPEAN JOURNAL OF CANCER
- Guidelines for the management of oesophageal and gastric cancer
- (2011) W. H. Allum et al. GUT
- Comparison of the Prognostic Value of Tumour- and Patient-Related Factors in Patients Undergoing Potentially Curative Resection of Oesophageal Cancer
- (2011) Sumanta Dutta et al. WORLD JOURNAL OF SURGERY
- Fc R2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
- (2010) K. Tamura et al. ANNALS OF ONCOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus
- (2010) U. Zingg et al. EJSO
- Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer
- (2010) J. A. D. Simpson et al. GUT
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy
- (2009) Khaleel R Fareed et al. HISTOPATHOLOGY
- Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales
- (2008) Côme Lepage et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Cancer treatment: the combination of vaccination with other therapies
- (2008) Mads Hald Andersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
- (2008) S. Ladoire et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started